Literature DB >> 25673907

Blocking the expression of syntaxin 4 interferes with initial phagocytosis of Brucella melitensis in macrophages.

Alfredo Castañeda-Ramírez1, Diana González-Rodríguez1, J Aide Hernández-Pineda1, Antonio Verdugo-Rodríguez1.   

Abstract

Brucella melitensis is the Brucella species most frequently associated with brucellosis in humans. It is also the causative agent of the disease in goats and other ruminants. Although significant aspects of the pathogenesis of infection by this intracellular pathogen have been clarified, several events during invasion of host cells remain to be elucidated. In this study, infections of human macrophages from the THP-1 monocyte cell line were conducted with B. melitensis Bm133 wild-type strain and a strain of Salmonella serovar Enteritidis as a control. A multiplicity of infection of 100 was used in trials focused on defining the relative expression of syntaxin 4 (STX4), a soluble N-ethylmaleimide-sensitive factor attachment protein receptor, in the early events of phagocytosis (at 15, 30, 45, and 60 min). Immunoblot assays were also done to visualize expression of the protein in cells infected with either bacterial strain. The expression of STX4 was not significantly different in cells infected with B. melitensis strain Bm133 compared to that observed in cells infected with S. Enteritidis. When the expression of STX4 mRNA was inhibited with short or small interfering, or silencing, RNA in the THP-1 cells, the survival of B. melitensis was significantly reduced at time 0, when gentamicin treatment of cultures was begun (after 1 h of phagocytosis), and also at 2 h and 12 h after infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673907      PMCID: PMC4283232     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  37 in total

1.  Quantitative and dynamic assessment of the contribution of the ER to phagosome formation.

Authors:  Nicolas Touret; Paul Paroutis; Mauricio Terebiznik; Rene E Harrison; Sergio Trombetta; Marc Pypaert; Amy Chow; Aimin Jiang; James Shaw; Christopher Yip; Hsiao-Ping Moore; Nicole van der Wel; Diane Houben; Peter J Peters; Chantal de Chastellier; Ira Mellman; Sergio Grinstein
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

2.  Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.

Authors:  J Pizarro-Cerdá; E Moreno; V Sanguedolce; J L Mege; J P Gorvel
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival.

Authors:  Beatriz Arellano-Reynoso; Nicolas Lapaque; Susana Salcedo; Gabriel Briones; Andrés Eduardo Ciocchini; Rodolfo Ugalde; Edgardo Moreno; Ignacio Moriyón; Jean-Pierre Gorvel
Journal:  Nat Immunol       Date:  2005-05-08       Impact factor: 25.606

4.  A role for the phagosome in cytokine secretion.

Authors:  Rachael Z Murray; Jason G Kay; Daniele G Sangermani; Jennifer L Stow
Journal:  Science       Date:  2005-11-10       Impact factor: 47.728

5.  Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking.

Authors:  Nadim Shohdy; Jem A Efe; Scott D Emr; Howard A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

6.  Brucella coopts the small GTPase Sar1 for intracellular replication.

Authors:  Jean Celli; Suzana P Salcedo; Jean-Pierre Gorvel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-04       Impact factor: 11.205

7.  Silencing of VAMP3 expression does not affect Brucella melitensis infection in mouse macrophages.

Authors:  Alfredo Castañeda-Ramírez; José L Puente; Alfonso González-Noriega; Antonio Verdugo-Rodríguez
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

8.  Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system.

Authors:  Maarten F de Jong; Yao-Hui Sun; Andreas B den Hartigh; Jan Maarten van Dijl; Renée M Tsolis
Journal:  Mol Microbiol       Date:  2008-10-24       Impact factor: 3.501

9.  Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3.

Authors:  H Schwende; E Fitzke; P Ambs; P Dieter
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

10.  Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis.

Authors:  Supriya Christopher; B L Umapathy; K L Ravikumar
Journal:  J Lab Physicians       Date:  2010-07
View more
  4 in total

1.  Assessment of Association between miR-146a Polymorphisms and Expression of miR-146a, TRAF-6, and IRAK-1 Genes in Patients with Brucellosis.

Authors:  Sima Kazemi; Saeid Afshar; Fariba Keramat; Massoud Saidijam; Manoochehr Karami; Seyed Hamid Hashemi; Mohammad Yousef Alikhani
Journal:  Mol Biol Rep       Date:  2022-01-04       Impact factor: 2.316

2.  Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis.

Authors:  Ferah Budak; Salih Haldun Bal; Gulcin Tezcan; Halis Akalın; Guher Goral; Haluk Barbaros Oral
Journal:  J Immunol Res       Date:  2016-09-19       Impact factor: 4.818

Review 3.  Establishment of Chronic Infection: Brucella's Stealth Strategy.

Authors:  Waqas Ahmed; Ke Zheng; Zheng-Fei Liu
Journal:  Front Cell Infect Microbiol       Date:  2016-03-15       Impact factor: 5.293

Review 4.  microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment.

Authors:  Sima Kazemi; Rasoul Mirzaei; Mohammad Sholeh; Sajad Karampoor; Fariba Keramat; Massoud Saidijam; Mohammad Yousef Alikhani
Journal:  Immun Inflamm Dis       Date:  2021-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.